LungLife AI Inc (LSE:LLAI) — Stock Price
LungLife AI Inc (LSE:LLAI) is currently trading at GBX4.15 GBX, up 0.00% today. Over the past 52 weeks, shares have ranged between GBX4.15 and GBX4.15. This page tracks LungLife AI Inc's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see LungLife AI Inc (LLAI) market capitalisation.
LungLife AI Inc (LLAI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks LungLife AI Inc's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Daily price history is not currently available for LungLife AI Inc.
LungLife AI Inc Income Statement — Revenue, Profit & Earnings by Year
LungLife AI Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Revenue | GBX46.00K | GBX24.00K | GBX195.57K | GBX205.18K | GBX136.49K |
| Cost of Revenue | GBX0.00 | GBX0.00 | GBX96.27K | GBX188.18K | GBX149.89K |
| Gross Profit | GBX46.00K | GBX24.00K | GBX99.30K | GBX17.00K | GBX-13.40K |
| Research & Development | GBX1.31 Million | GBX1.98 Million | GBX1.34 Million | GBX647.15K | — |
| SG&A | GBX1.34 Million | GBX6.87 Million | GBX1.93 Million | GBX3.80 Million | GBX3.10 Million |
| Total Operating Expenses | GBX5.68 Million | GBX7.66 Million | GBX5.44 Million | GBX4.08 Million | GBX3.40 Million |
| Operating Income | GBX-5.63 Million | GBX-7.64 Million | GBX-5.34 Million | GBX-4.06 Million | GBX-3.41 Million |
| EBITDA | GBX-5.11 Million | GBX-7.26 Million | GBX-6.69 Million | GBX-3.78 Million | GBX-3.11 Million |
| EBIT | GBX-5.37 Million | GBX-7.55 Million | GBX-7.01 Million | GBX-4.06 Million | GBX-3.41 Million |
| Interest Expense | GBX41.00K | GBX52.00K | GBX416.93K | GBX777.19K | GBX558.43K |
| Income Before Tax | GBX-5.41 Million | GBX-7.60 Million | GBX-7.43 Million | GBX-4.84 Million | GBX-3.97 Million |
| Income Tax Expense | GBX7.00K | GBX4.00K | GBX15.87K | GBX777.19K | GBX765.49K |
| Net Income | GBX-5.41 Million | GBX-7.61 Million | GBX-7.44 Million | GBX-5.62 Million | GBX-4.74 Million |
LungLife AI Inc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes LungLife AI Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Assets | GBX9.52 Million | GBX15.02 Million | GBX21.97 Million | GBX21.52 Million | GBX1.73 Million |
| Total Current Assets | GBX3.30 Million | GBX8.62 Million | GBX15.37 Million | GBX21.04 Million | GBX978.72K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | GBX104.00K | GBX4.92 Million | GBX5.41 Million | — | — |
| Net Receivables | GBX175.00K | GBX463.00K | GBX48.59K | GBX0.00 | GBX9.80K |
| Inventory | GBX-175.00K | — | — | — | — |
| Property, Plant & Equipment | — | GBX566.00K | GBX765.98K | GBX463.44K | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | GBX1.61 Million | GBX1.88 Million | GBX1.84 Million | GBX1.99 Million | GBX8.53 Million |
| Total Current Liabilities | GBX1.45 Million | GBX1.48 Million | GBX1.19 Million | GBX1.78 Million | GBX8.14 Million |
| Long-term Debt | — | — | — | — | GBX0.00 |
| Net Debt | GBX-2.38 Million | GBX-2.49 Million | GBX-13.82 Million | GBX-20.33 Million | GBX6.95 Million |
| Total Stockholder Equity | GBX7.91 Million | GBX13.14 Million | GBX20.13 Million | GBX19.53 Million | GBX-6.80 Million |
| Retained Earnings | GBX-85.12 Million | GBX-79.70 Million | GBX-72.10 Million | GBX-64.90 Million | GBX-60.06 Million |
LungLife AI Inc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how LungLife AI Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-5.02 Million | GBX-5.84 Million | GBX-7.54 Million | GBX-2.87 Million | GBX-3.32 Million |
| Capital Expenditures | GBX77.00K | GBX85.00K | GBX1.85 Million | GBX5.33K | GBX91.91K |
| Free Cash Flow | GBX-5.10 Million | GBX-5.93 Million | GBX-9.39 Million | GBX-2.88 Million | GBX-3.41 Million |
| Investing Cash Flow | — | GBX-115.00K | GBX-1.80 Million | GBX-5.33K | — |
| Financing Cash Flow | GBX-296.00K | GBX-169.00K | GBX23.84 Million | GBX2.28 Million | GBX3.92 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | GBX186.00K | GBX614.00K | GBX409.00K | GBX225.63K | GBX48.40K |
| Depreciation | GBX254.00K | GBX285.00K | GBX323.76K | GBX282.65K | GBX302.44K |
| Change in Cash | GBX-364.00K | GBX-6.13 Million | GBX14.50 Million | GBX-599.17K | GBX504.39K |
LungLife AI Inc Earnings History — EPS Actual vs. Analyst Estimates
Track LungLife AI Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for LungLife AI Inc.